The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Discovering and improving novel peptide therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
RNA-peptide fusions for the in vitro selection of peptides and proteins
Roberts, R. W., & Szostak, J. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12297 · Cited by 1,105
Kuter, D. J., Bussel, J. B., Lyons, R. M., Pullarkat, V., Gernsheimer, T. B., Senecal, F. M., Aledort, L. M., George, J. N., Kessler, C. M., Sanz, M. A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60203-2 · Cited by 867
Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin
Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K., & Dower, W. J. (1996) · Science · doi:10.1126/science.273.5274.458 · Cited by 672
Strategies to improve plasma half life time of peptide and protein drugs
Werle, M., & Bernkop-Schnürch, A. (2006) · Amino Acids · doi:10.1007/s00726-005-0289-3 · Cited by 660
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 598
An in vitro polysome display system for identifying ligands from very large peptide libraries.
Mattheakis, L. C., Bhatt, R. R., & Dower, W. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9022 · Cited by 514
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
Dennis, M. S., Zhang, M., Meng, Y. G., Kadkhodayan, M., Kirchhofer, D., Combs, D., & Damico, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205854200 · Cited by 508
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Tang, X., Kim, H., Meyer, S., Han, S. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.030 · Cited by 471
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
Vaccaro, C., Zhou, J., Ober, R. J., & Ward, E. S. (2005) · Nature Biotechnology · doi:10.1038/nbt1143 · Cited by 407
Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target
Zahnd, C., Amstutz, P., & Plückthun, A. (2007) · Nature Methods · doi:10.1038/nmeth1003 · Cited by 308
Albinterferon α-2b: a genetic fusion protein for the treatment of chronic hepatitis C
Subramanian, G. M., Fiscella, M., Lamousé-Smith, A., Zeuzem, S., & McHutchison, J. G. (2007) · Nature Biotechnology · doi:10.1038/nbt1364 · Cited by 216
Cell-penetrating peptides for drug delivery across membrane barriers
Foged, C., & Nielsen, H. M. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.105 · Cited by 205
Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
Holt, L. J., Basran, A., Jones, K., Chorlton, J., Jespers, L. S., Brewis, N. D., & Tomlinson, I. M. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm067 · Cited by 193
Skerra, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06439.x · Cited by 176
Novel Delivery Technologies for Protein and Peptide Therapeutics
Shantha Kumar, T., Soppimath, K., & Nachaegari, S. (2006) · Current Pharmaceutical Biotechnology · doi:10.2174/138920106777950852 · Cited by 161
CIS display: In vitro selection of peptides from libraries of protein–DNA complexes
Odegrip, R., Coomber, D., Eldridge, B., Hederer, R. A., Kuhlman, P. A., Ullman, C. G., FitzGerald, K., & McGregor, D. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400219101 · Cited by 147
Self-citationOn The Biomedical Promise of Cell Penetrating Peptides: Limits Versus Prospects
Foerg, C., & Merkle, H. P. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21117 · Cited by 141
Artificial, non-antibody binding proteins for pharmaceutical and industrial applications
Hey, T., Fiedler, E., Rudolph, R., & Fiedler, M. R. M. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.07.007 · Cited by 136
Synthesis, Characterization, and Pharmacokinetic Studies of PEGylated Glucagon-like Peptide-1
Lee, S., Lee, S., Youn, Y. S., Na, D. H., Chae, S. Y., Byun, Y., & Lee, K. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049735+ · Cited by 123
Fan, Q., Leuther, K. K., Holmes, C. P., Fong, K. L., Zhang, J., Velkovska, S., Chen, M., Mortensen, R. B., Leu, K., Green, J. M., et al. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.05.012 · Cited by 114
Stead, R. B., Lambert, J. S., Wessels, D., Iwashita, J., Leuther, K. K., Woodburn, K. W., Schatz, P. J., Okamoto, D. M., Naso, R. B., & Duliège, A. (2006) · Blood · doi:10.1182/blood-2006-04-015818 · Cited by 111
He, X., Shaw, P., & Tam, S.-C. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00257-x · Cited by 93
Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway
Bitonti, A. J., & Dumont, J. A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.015 · Cited by 89
Na, D. H., Lee, K. C., & DeLuca, P. P. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2590-y · Cited by 69
A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases
Shrivastava, A., von Wronski, M. A., Sato, A. K., Dransfield, D. T., Sexton, D. J., Bogdan, N. J., Pillai, R., Nanjappan, P., Song, B., Marinelli, E. R., et al. (2005) · Protein Engineering Design and Selection · doi:10.1093/protein/gzi049 · Cited by 55
DNA Display of Biologically Active Proteins for In Vitro Protein Selection
Yonezawa, M. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh034 · Cited by 40
Abraham, S., Guo, F., Li, L., Rader, C. M., Liu, C., Barbas, C. F., Lerner, R. A., & Sinha, S. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700223104 · Cited by 40
Comparison of mRNA-Display-Based Selections Using Synthetic Peptide and Natural Protein Libraries
Huang, B., & Liu, R. (2007) · Biochemistry · doi:10.1021/bi700220x · Cited by 25
Structure–activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction
Mezo, A. R., McDonnell, K. A., Castro, A., & Fraley, C. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.004 · Cited by 24
Woodburn, K. W., Schatz, P. J., Fong, K. L., Wilson, S. D., Ferrell, T., Spainhour, C. B., & Norton, D. (2008) · Drug and Chemical Toxicology · doi:10.1080/01480540701873186 · Cited by 21
Increasing the platelet count in chronic ITP
Nurden, A. T., & Nurden, P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60178-6 · Cited by 4
Cited by
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Improved Docking of Polypeptides with Glide
Tubert-Brohman, I., Sherman, W., Repasky, M., & Beuming, T. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400128m · Cited by 1,308
Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics
Góngora-Benítez, M., Tulla-Puche, J., & Albericio, F. (2014) · Chemical Reviews · doi:10.1021/cr400031z · Cited by 655
Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery
Habibi, N., Kamaly, N., Memic, A., & Shafiee, H. (2016) · Nano Today · doi:10.1016/j.nantod.2016.02.004 · Cited by 619
Metadata
- Authors
- MCGREGOR, D.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 8
- Issue
- 5
- Pages
- 616-619
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2088877201
- Cited by
- 331
- References
- 32
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.